Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-32 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
filingDate |
2005-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42fa800255c7556866f9f005fe45d4e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d7d1faefaa37531d8ab5a07bf48def4 |
publicationDate |
2010-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7795389-B2 |
titleOfInvention |
Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combination or as fusion proteins |
abstract |
Anti-cancer agents and/or transforming growth factor beta (TGF-beta or TGFβ) antagonists are disclosed, where the agents and/or antagonists include a therapeutically effective amount of a combination of therapeutically active portions of sRII and therapeutically active portions of sRIII or a fusion polypeptide or protein comprising therapeutically active portions of sRII and therapeutically active portions of sRIII. Methods for preventing, treating and/or ameliorating the symptoms of cancer are also disclosed based on administering an effective amount of a composition of this invention. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8658135-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013039911-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11692042-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9441044-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10316076-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9809637-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9850306-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993524-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884900-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11274156-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10981973-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11203624-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11008377-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10442860-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011236309-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11021527-B2 |
priorityDate |
2004-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |